Galen Medical Nutrition announces launch of TYR EASY Tablets in the UK

Galen  the privately-owned pharmaceutical sales, and marketing company, has today announced the launch of their TYR EASY Tablets, the first solid-dose protein substitute option for tyrosinaemia, into the UK market.  Galen’s TYR EASY Tab...

Read more

Galen and The College of Paramedics award Barry Costello as Winner of the Dr John Hinds Scholarship Award 2022

Galen, in association with the College of Paramedics and The ATACC Group, is proud to name Barry Costello as the winner of the Dr John Hinds Scholarship Award 2022. Barry was presented his award at a celebratory afternoon tea at the International...

Read more

Galen Announces Medical Nutrition Scholarship Award Winners for 2022

Galen is proud to announce the winners of the Galen Medical Nutrition Scholarship Award for 2022 as Stuart Noble from Merseyside, England and Kaisa Minnie Haugen from Stjørdal in Norway. The scholarship was on offer to people with metabolic disor...

Read more

POA Pharma, enters the German market, securing exclusive in-licensing rights for Rapilose Oral Glucose Solution (OGS)

POA Pharma Scandinavia AB, a Galen Limited owned company, has announced its entry into the German market, securing an exclusive in-licensing agreement with Penlan Healthcare Limited for Rapilose OGS. POA Pharma’s parent company, Galen Limited, a ...

Read more

Galen Medical Nutrition Announces Scholarship Award is open for applications

Supporting patients with metabolic disorders accessing further education Galen, the privately-owned pharmaceutical sales and marketing company, has announced that the application process for their Medical Nutrition Scholarship Award is now open. ...

Read more

Galen expands product portfolio with GelX® Oral Spray

Galen, a global pharmaceutical company, and part of the Almac Group headquartered in Craigavon, has announced a new partnership with Sunstar Suisse S.A. to exclusively distribute and commercialise GelX® Oral Spray in the United Kingdom and Ireland...

Read more

Galen expands product portfolio with Provocholine® (methacholine chloride)

Galen, a global pharmaceutical company, and part of the Almac Group headquartered in Craigavon, has acquired the rights to Provocholine® 100 mg Powder for nebuliser solution (methacholine chloride), manufactured by Methapharm Specialty Pharmaceuti...

Read more

The College of Paramedics Opens Dr John Hinds Scholarship Call for Entries

Craigavon, N.I., Tuesday 1st Febraury 2022- The College of Paramedics, in association with Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications for this year’s Dr John Hinds Scholarshi...

Read more

Nexus Patient Services Announces Distribution Agreement with Galen Medical Nutrition

October 15, 2021  Nexus Patient Services today announced an agreement with Galen US Inc. to become the sole distributor for Galen Medical Nutrition in the United States. This agreement allows Nexus to provide continued access to Galen’s high...

Read more

Galen Announces Medical Nutrition Scholarship Award Winners 2021

Ella Roberts (Wilshire, England) and Fergal Egan (Limerick, Ireland) named winners of the inaugural program Craigavon, U.K. – 20 September 2021 - Galen, the privately-owned pharmaceutical sales and marketing company, is proud to announce the winn...

Read more

Galen Medical Nutrition Announces Scholarship Award

Supporting patients with metabolic disorders accessing further education Craigavon, U.K. – 27 Jul 2021 - Galen, the privately-owned pharmaceutical sales and marketing company, is pleased to announce the inaugural Galen Medical Nutrition Scholarsh...

Read more

Dr John Hinds Scholarship Award Winner Announced

Craigavon, U.K. – 18 May 2021 - The College of Paramedics, in association with Galen, the privately owned pharmaceutical sales and marketing company, is proud to announce the winner of the Dr John Hinds Scholarship Award 2021: Edel Mullen of Natio...

Read more

NI Chamber in conversation with Dr Dennise Broderick - Managing Director, Galen

Dr Dennise Broderick, Managing Director & President of Galen, shares how combining a passion for science and love of business has shaped her extensive career and catapulted her to leadership roles with pharmaceutical companies across the globe...

Read more

The College of Paramedics Opens Dr John Hinds Scholarship Call for Entries

Craigavon, N.I., 25 January 2021 – The College of Paramedics, in association with Galen, the privately-owned pharmaceutical sales and marketing company is pleased to announce that applications for this year’s Dr John Hinds Scholarship Award will o...

Read more

Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19

Employee-driven initiative will benefit 33 health and welfare organisations local to Almac’s 11 global facilities Craigavon, Northern Ireland - 02 September 2020 – Almac Group has today announced the organisation will donate £250,000 to 33 charit...

Read more

Announcing the Winner of the Dr John Hinds Scholarship Award 2020

Craigavon, U.K. – 16 Jun 2020 - Today, the College of Paramedics, in association with Galen, the privately owned pharmaceutical sales and marketing company, is proud to announce the winner of the Dr John Hinds Scholarship Award 2020: Orla Morrow o...

Read more

Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments

Inhaled analgesic can save average patient 71 minutes for some common injuries compared to traditional therapies Craigavon, N.I., Tuesday 31 March 2020 - An inhaled analgesic recently introduced to the UK can save more than one hour per appropria...

Read more

Call for entries for the Dr John Hinds Scholarship

More News

Read more

Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK

Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK   Craigavon, N.I., 13 Feb 2020 – An innovative medical food (food for special medical purpose) for people living with t...

Read more

Galen Announces Completion of Multi-Million Pound POA Pharma Acquisition

Move adds substantial new therapeutic areas and territories to Galen’s reach Craigavon, N.I., 8 Jan 2020 - Galen, the privately owned global pharmaceutical sales and marketing company, today announced the completion of a multi-million pound acqui...

Read more

Galen attends the Royal College of Emergency Medicine annual scientific meeting 2019

Galen were this year’s platinum sponsors at the Royal College of Emergency Medicine annual scientific meeting in The Sage, Gateshead. The Galen Penthrox team spent three days with some of emergency medicine’s key opinion leaders in what was a tru...

Read more

NI Chamber Puts Dr Dennise Broderick under the Spotlight

Galen President and MD first keynote speaker in CEO Spotlight Series Craigavon, N.I., 7 Oct 2019 - Dr. Dennise Broderick, President and Managing Director of global speciality pharmaceutical company, Galen, was the first member to participate in N...

Read more

Dr Dennise Broderick, President and Managing Director of Galen, explains her commitment to driving growth with a strong focus on the customer and the patient.

Driving growth through patient focus Dr Dennise Broderick, President and Managing Director of Galen (a member of the Almac Group), explains her commitment to driving growth with a strong focus on the customer and the patient. Article published i...

Read more

Galen Appoints Dr Dennise Broderick as Managing Director

15th January 2019 | Galen Ltd, the Northern Ireland based pharmaceutical company, is delighted to announce the appointment of Dr Dennise Broderick as its new Managing Director and President. She will report to Alan Armstrong, CEO and Chairman, Alm...

Read more

Galen expands further into US with significant acquisition

11th July 2013 | Galen Ltd, the Craigavon-based pharmaceutical company that is part of Almac Group, has reached a significant deal with a US company to acquire the rights to a leading medicinal product. Galen US, Inc., a wholly owned subsidiary o...

Read more

Galen acquires Synera

11th July 2013 | SOUDERTON, PENNSYLVANIA Galen, a Northern Ireland based pharmaceutical company, has acquired Synera® (lidocaine 70mg/tetracaine 70mg) topical patch from ZARS Pharma Inc., a wholly owned subsidiary of Nuvo Research Inc. Synera® is...

Read more

Would you like to discuss how Galen can help you?

If you would like to explore how our expertise could add value to your product, or for an initial discussion about partnering with us, please contact our team.